Developmental changes of vitamin K epoxidase and reductase activities involved in the vitamin K cycle in human liver

Early Human Development

Volumn 57, Issue 1, 2000, Pages 15-23

  Itoh, Susumu ^a   Onishi, Shoju ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Human autopsied liver; Vitamin K cycle; Vitamin K epoxidase; Vitamin K reductase; Vitamin K 2,3 epoxide reductase

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); VITAMIN K DEPENDENT CARBOXYLASE;

ARTICLE; AUTOPSY; DEVELOPMENT; ENZYME ACTIVITY; FETUS; HUMAN; HUMAN TISSUE; LIVER; NEWBORN; PERINATAL PERIOD; PRENATAL PERIOD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; LIVER; MIXED FUNCTION OXYGENASES; NAD(P)H DEHYDROGENASE (QUINONE); PREGNANCY; VITAMIN K;

EID: 0033989805     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-3782(99)00050-X     Document Type: Article

References (38)

1. Hanawa Y. Vitamin K deficiency in infancy: the Japanese experience. Acta Paediatr Jpn 1972;34:107-16.
2. Suttie JW. Mechanism of action of vitamin K: synthesis of gamma-carboxyglutamic acid. Crit Rev Biochem 1980;8:191-223.
3. Shearer MJ, McCarthy PT, Crampton OE, Mattock MB. The assessment of human vitamin K status from tissue measurements. In: Suttie JW, editor, Current advances in vitamin K research, New York: Elsevier, 1988, pp. 437-52.
4. Onishi S, Isobe K, Itoh S, Fukuzaki R, Kunikata T, Ochi M. Dynamic changes in serum vitamin K concentrations in the perinatal period. Ministry of Health and Welfare of Japan for Research on Prevention of Physical and Mental Disabilities, Tokyo, 1988:52-55 (in Japanese).
5. Sugiura I, Furie B, Walsh CT, Furie BC. Propeptide and glutamate-containing substrates bound to the vitamin K-dependent carboxylase convert its vitamin K epoxidase function from an inactive to an active state. Proc Natl Acad Sci USA 1997;94:9069-74.
6. Gardill SL, Suttie JW. Vitamin K epoxide and quinone reductase activities: evidence for reduction by a common enzyme. Biochem Pharmacol 1990;40:1055-61.
7. Egeberg K, Helgeland L. Vitamin K epoxidase activity of rough and smooth microsomes from rat liver. Biochim Biophys Acta 1980;627:225-9.
8. Wallin R, Martin LF. Warfarin poisoning and vitamin K antagonism in rat and human liver: design of a system in vitro that mimics the situation in vivo. Biochem J 1987;241:389-96.
9. Wallin R. Vitamin K antagonism and coumarin anticoagulant drug: a study of an enzymatic pathway in rat liver that is responsible for the antagonistic effect. Thromb Haemost 1985;54:150a, (abstr).
10. Fasco MJ, Hildebrandt EF, Suttie JW. Evidence that warfarin anticoagulant action involves two distinct reductase activities. J Biol Chem 1982;257:11210-2.
11. Vermeer C. γ-Carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J 1990;266:625-36.
12. Kawalek JC, Andrews AW. The effect of solvents on drug metabolism in vitro. Drug Metab Dispos 1980;8:380-4.
13. Helgeland L, Christensen TB, Janson TL. The distribution of protein-bound carbohydrates in submicrosomal fractions from rat liver. Biochim Biophys Acta 1972;286:62-71.
14. 1 in plasma, with fluorometric detection. Clin Chem 1986;32:1925-9.
15. 1 and its implications in fetal hemostasis. Thromb Haemost 1988;60:39-43.
16. Uchida K, Komeno T. Relationships between dietary and intestinal vitamin K, clotting factor level, plasma vitamin K and urinary Gla. In: Suttie JW, editor, Proceedings of the Seventeenth Steenbock Symposium on Current Advances in Vitamin K Research, New York: Elsevier, 1988, pp. 477-92.
17. Pauli RM, Lian JB, Mosher DF, Suttie JW. Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of teratogenicity of of coumarin derivatives. Am Hum Genet 1987;41:566-83.
18. Nakano T, Kawamoto K, Kishino J, Nomura K, Higashino K, Arita H. Requirement of γ-carboxyglutamic acid residues for the biological activity of Gas6:contribution of endogenous Gas6 to the proliferation of vascular smooth muscle cells. Biochem J 1997;323:387-92.
19. Golding J, Greenwood R, Birmingham K, Mott M. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. Br Med J 1992;305:341-6.
20. Ekelund H, Finnstroem O, Gunnarskog J, Kallen B Larsson Y Administration of vitamin K to newborn infants and childhood cancer. Br Med J 1993;307:89-91.
21. Klebanoff MA, Read JS, Mills JL, Shiono PH. The risk of childhood cancer after neonatal exposure to vitamin K. N Engl J Med 1993;329:905-8.
22. Gallop PM, Friedman PA, Henson E. A radical-radical C-carboxylation reaction as a model related to the vitamin K-dependent carboxylation. In: Suttie JW, editor, Vitamin K metabolism and vitamin K dependent proteins, Baltimore: Univ. Park Press, 1980, pp. 408-12.
23. Canfield ML. Vitamin K-dependent oxygenase/carboxylase vitamin K binding to thiol. In: Suttie JW, editor, Current advances in vitamin K research, New York, Amsterdam, London: Elsevier, 1988, pp. 55-8.
24. Cheung AY, Wood GM, Funakawa S, Grossman CP, Suttie JW. Vitamin K-dependent carboxylase: substrates, products, and inhibitors. In: Suttie JW, editor, Current advances in vitamin K research, New York, Amsterdam, London: Elsevier, 1988, pp. 3-16.
25. Rao PS, Olson RE. Identity of peroxy radicals produced from vitamin K in oxygenated solutions as studied by pulse radiolysis technique. Biochem Biophys Res Commun 1982;105:231-5.
26. 2O into glutamic acid residues. J Biol Chem 1983;258:12129-31.
27. Iyanagi T, Yamazaki I. One-electron-transfer reactions in biochemical systems; V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase). Biochim Biophys Acta 1970;216:282-94.
28. Hassan HM, Fridovich I. Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds. Arch Biochem Biophys 1979;196:385-95.
29. Turrents JF, Alexandre A, Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 1985;237:408-14.
30. 2+ release from rat-liver mitochondria is caused by NAD(P)H oxidation. Xenobiotics 1986;16:873-82.
31. Rice JM. Problems and perspectives in perinatal carcinogenesis: a summary of the conference. Natl Cancer Inst Monogr 1979;51:271-8.
32. Rice JM. Fetal susceptibility to viral and chemical carcinogens. Lab Invest 1988;58:1-4.
33. Wiss O, Gloor H. Absorption, distribution, storage, and metabolites of vitamin K and related quinones. Vitam Horm 1966;24:575-86.
34. 1) in man. Vitam Horm 1974;32:513-42.
35. Onishi S, Kawade N, Itoh S, Isobe K, Sugiyama S. Postnatal development of urine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver. Biochem J 1979;184:705-7.
36. 1 as a modulator of benzo(a)pyrene metabolism as measured by in vitro metabolite formation and in vivo DNA-adduct formation. Int J Biochem 1985;17:1263-6.
37. 1 amplification of benzo(a)pyrene metabolism in chick embryos. Int J Biochem 1987;19:471-3.
38. 1 deficit in the newborn. Semin Perinatol 1997;21:90-6.